Deakin University
Browse
orford-perioperativecomplications-2007.pdf (130.83 kB)

Perioperative complications in patients with drug-eluting stents: a three-year audit at Geelong Hospital

Download (130.83 kB)
Version 2 2024-06-03, 17:34
Version 1 2019-07-15, 14:09
journal contribution
posted on 2024-06-03, 17:34 authored by M Conroy, SNC Bolsin, SA Black, Neil OrfordNeil Orford
Drug-eluting stents are a recommended treatment for lesions in the coronary arteries. Stent insertion requires the patient remain on antiplatelet medication for a minimum of six months after insertion. A serious consequence of ceasing antiplatelet medication is late stent thrombosis leading to myocardial infarction in the territory of the drug-eluting stent. Continuing antiplatelet medication can lead to excessive bleeding at the time of surgery. Understanding the risk of complications attributable to bleeding or myocardial ischaemia will help in defining the optimal management of these patients at the time of noncardiac surgery. This study is a retrospective database analysis and case note review of all patients with drug-eluting stents presenting for noncardiac surgical procedures over a three-year period in one centre. Twenty-four patients with drug-eluting stents inserted presented for 43 noncardiac surgical procedures. Severe bleeding problems were encountered in one case. Three of 15 patients (20%) who ceased clopidogrel prior to surgery without alternative anti-thrombotic prophylaxis suffered myocardial infarction due to stent thrombosis. Four patients who received alternative anti-thrombotic prophylaxis did not suffer complications. All 19 patients who ceased clopidogrel remained on aspirin prior to surgery. Patients treated with drug-eluting stents for coronary artery stenosis represent a challenging group of patients for subsequent perioperative management. The risk of myocardial infarction when clopidogrel is stopped prior to surgery is 20%, if alternative anti-thrombotic prophylaxis is not used. This risk persists beyond one year after insertion of drug-eluting stents. Some treatments appear to be effective in reducing the risk of myocardial infarction.

History

Journal

Anaesthesia and intensive care

Volume

35

Pagination

939-944

Location

London, Eng.

Open access

  • Yes

ISSN

0310-057X

eISSN

1448-0271

Language

eng

Publication classification

C1.1 Refereed article in a scholarly journal

Copyright notice

2007, SAGE Publications

Issue

6

Publisher

SAGE Publications

Usage metrics

    Research Publications

    Categories

    No categories selected

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC